Allogene Therapeutics Inc (ALLO) Q3 2024 Earnings Call Highlights: Financial...

Published on 8 Nov 2024 on GuruFocus.com · via Yahoo Finance

Allogene Therapeutics Inc (ALLO) reports a strong cash position and promising clinical progress,...

Read the rest of the article

Start tracking your investments with Statfolio

Allogene Therapeutics Inc (ALLO) reports a strong cash position and promising clinical progress,...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

Allogene Therapeutics Inc (NASDAQ:ALLO) is set to release its Q3 2024 earnings on Nov 7, 2024. Th...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

We recently compiled a list of the 7 Best Rising Penny Stocks To Invest In Now. In this article, ...

Insider Monkey · via Yahoo Finance 6 Oct 2024

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. ...

Insider Monkey · via Yahoo Finance 19 Sep 2024

Key Insights Significantly high institutional ownership implies Allogene Therapeutics' stock pric...

Simply Wall St. · via Yahoo Finance 18 Jun 2024

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 18 Jun 2024

One stock that might be an intriguing choice for investors right now is Allogene Therapeutics, In...

Zacks via Yahoo Finance 8 Apr 2024

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript March 14, 2024 Allogen...

Insider Monkey via Yahoo Finance 16 Mar 2024

Allogene Therapeutics, Inc. ALLO incurred an adjusted loss (excluding impairment of long-lived as...

Zacks via Yahoo Finance 15 Mar 2024

This collaboration aims to advance the development of treatments for autoimmune diseases using...

Investing.com 11 Mar 2024